111 Capital’s Inspire Medical Systems INSP Stock Holding History

111 Capital’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,309	Closed	-$300K	–	579
2025 Q2	$300K	Buy	+2,309	New	+$335K	0.05%	361

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

111 Capital's INSP Position: Q3 2025 in Review

111 Capital sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 2,309 shares — an estimated $300K sold.

111 Capital first reported a position in INSP in Q2 2025 and held it in 1 quarter. The position peaked at $300K in Q2 2025. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

111 Capital reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
111 Capital sold 2,309 Inspire Medical Systems shares in Q3 2025, an estimated $300K.
111 Capital first reported a position in Inspire Medical Systems in Q2 2025 and held it in 1 quarter.
111 Capital's Inspire Medical Systems position peaked at $300K in Q2 2025.
325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on 111 Capital's 13F filing for Q3 2025, filed 12 Nov 2025.